Newracom’s Wi-Fi 6 Patent Portfolio: A Dive Into Unacquired Assets & Their Potential

While early identification of Wi-Fi 7 SEPs is the long-term vision, immediate dominance in the wireless domain comes from identifying the sellers of Wi-fi 6 patents with enforceable portfolios. Wi-Fi 6 is an evolving market, and while innovating and filing patents once dominated, things have changed. With the emergence of Wi-Fi 7 and its ongoing […]
Build a Strong Wi-Fi 7 Patent Portfolio Before Market Entry

Major players like ZTE, Xiaomi, Zyxel, Sagemcom, Maxlinear, TP-Link, Buffalo, Gemtek, and a few others have already begun marketing their Wi-Fi 7 routers, following the certifications received from the Wi-Fi Alliance. The early days of Wi-Fi 6 were marked by a similar rush to market. However, Wi-Fi manufacturers such as D-Link, Sercom, and Acer (having […]
4 AI Tools For Every IP Professional to Swifty Understand the Patents

Like every other industry, Artificial Intelligence (AI) has also transformed intellectual property (IP). With reduced human effort, patent experts can refine how they read, analyze, and leverage IP. Unsurprisingly, multiple AI tools that make patents easier to understand have entered the market. This article presents the top 4 AI Tools for quick and easy understanding […]
The Trajenta Patent Thicket: Patents expiring in 2025

Trajenta, known for its effective glycemic control without weight gain, is a key player in the diabetes medication sector. This critical medication, known generically as Linagliptin, is on the brink of its patent expiration, presenting an opportunity for generic drug manufacturers to introduce their own generic versions. Manufactured by Boehringer Ingelheim, Trajenta® is an oral […]
Qi Standard Mapping: Smart IP Licensing Move to Boost Revenue

IP Licensing is no longer a unique practice in dynamic technology domains. However, the key to success lies in finding the smartest and most creative strategy for analyzing infringement, which can significantly increase the revenue generated from a single patent. But what exactly will be the smartest strategy? This case study exemplifies how QI standard mapping […]
Strategic Considerations After The New “Skilled Searcher” Standard For IPR Estoppel

Ironburg Inventions, known for its SCUF controllers, claimed that Valve’s Steam Controller infringed on its patents. Specifically, the patents in question were related to the back paddle design of controllers, a feature that SCUF Gaming has heavily marketed and patented. However, it isn’t these details of the case that make it worth mentioning but the […]
Quickly Identify Non-SEPs To Optimize Your SEP Licensing Strategy

Identifying Standard Essential Patents (SEPs) is a resource-intensive task, especially when dealing with a large patent portfolio. In this process, manual analysis is the preferred method, but examining patents that are unlikely to be SEPs can lead to inefficient portfolio management and limit strategic decision-making during SEP licensing. Therefore, to avoid investing valuable resources into […]
Recent Patent Oppositions in the Pharmaceutical Industry

The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these oppositions is crucial as it assists in developing effective strategies for launching generic versions of drugs. Moreover, it aids in identifying competitors that may be eating into market […]
Understanding the Farxiga®/Forxiga® Patent Thicket: What’s Changing in 2025

While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has been introduced in the form of Farxiga®/Forxiga®. Farxiga®/Forxiga® is the trade name for Dapagliflozin, by AstraZeneca. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, representing a novel […]
73 Drugs Losing Europe Exclusivity in 2024

In Europe, 2024 marks the year when exclusivity for a diverse range of drugs encompassing various therapeutic categories is set to expire. This includes established medications like Cabometyx and Zavicefta and breakthrough treatments like Tagrisso. The article provides a list of 73 such drug patents across diverse therapeutic categories, ranging from antivirals to antineoplastics, reflecting […]
Dolby’s Strategy to Double Versatile Video Coding Standard Patent Licensing Returns

Streaming crystal-clear 8K content on a phone without buffering, even on unreliable internet, is no longer a far-fetched thought. This seemingly magical experience relies heavily on the intricate video compression technologies developed by industry leaders like Dolby and JVC Kenwood. Although this is commonly known, these companies are being highlighted in this case study for […]
8 Months In, the Unitary Patent & Court: Unmasking Industry Reactions & Shaping Your Next Move

In the eight months since its introduction, the Unitary Patent System has initiated a significant transformation in the field of patent law within the European Union. This article aims to offer an insightful overview of the Unitary Patent and Unified Patent Court, shedding light on how this system benefits various sectors, the notable cases that […]
4 Plant-based innovations that make dairy-free products consumer acceptable

Even as customers’ demand for dairy-free products grows, sales of most plant-based products have sharply declined over the past year. One of the primary reasons consumers reject plant-based foods is that their taste is too different from what they’re used to. Source: https://www.fmi.org As a result, innovating in this space has become more like a […]
Arthritis Drug Patents Expiring 2024 – 2028

The arthritis treatment industry is characterized by its intense competitiveness, driving companies to invest significantly in research and development to secure leading arthritis drug patents. Consequently, the expiration of patents for this disease creates significant opportunities for companies specializing in generic medications. A notable example of the market dynamics in this industry is the case […]
5 Important Patent Portfolio Valuation Checks To Make Your Portfolio An Asset

Acquiring multiple patents over time will result in a portfolio that may or may not align with a company’s objectives, values, and goals. Therefore, to ensure a stronger, more relevant portfolio, it’s important to conduct a successful patent portfolio valuation, which involves a crucial step: relevancy checking. The primary objective of relevancy checking is to […]
Confirming Product Overlap in Patent Infringement Analysis with Limited Online Resources

The standard approach to prove product overlap during patent infringement analysis involves researching online resources such as product manuals, datasheets, and FAQs. However, online literature won’t always provide conclusive evidence for technology overlap in certain high-tech sectors such as LiDAR (Light Detection and ranging) and semiconductors. This issue is compounded by the complexity of the […]